FRBN | Forbion European Acquisition Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	17.00 - 22.23
52 Week Range	9.25 - 47.17
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	58,993
Average Volume	213,439
Shares Outstanding	15,812,499
Market Cap	334,118,104
Sector	Financial Services
Industry	Shell Companies
IPO Date	2022-02-01

Valuation
Profitability
Growth
Health
P/E Ratio	-105.65
Forward P/E Ratio	N/A
EPS	-0.20
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	0
Country	USA
Website	FRBN

Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe. The company was incorporated in 2021 and is based in Wilmington, Delaware.

FRBN's peers: LION

*Chart delayed

Analyzing fundamentals for FRBN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see FRBN Fundamentals page.

Watching at FRBN technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on FRBN Technicals page.